Connect with us

INDIA NEWS

Covaxin Maker Gets $19 Million For Development Of ‘Variant Proof’ Vaccine

Published

on

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a…

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Copyright © 2021 SouthAsianJournal